Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019

SELL
$20.34 - $32.66 $522,738 - $839,361
-25,700 Closed
0 $0
Q2 2019

Aug 16, 2019

BUY
$28.03 - $36.85 $61,666 - $81,070
2,200 Added 9.36%
25,700 $816,000
Q1 2019

May 14, 2019

BUY
$28.71 - $33.65 $674,685 - $790,775
23,500 New
23,500 $776,000
Q4 2018

Feb 08, 2019

SELL
$31.18 - $44.64 $452,110 - $647,280
-14,500 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$38.7 - $48.1 $34,830 - $43,290
-900 Reduced 5.84%
14,500 $668,000
Q1 2018

May 03, 2018

SELL
$32.2 - $40.45 $6,440 - $8,090
-200 Reduced 1.28%
15,400 $611,000
Q4 2017

Feb 14, 2018

BUY
$32.65 - $37.9 $509,340 - $591,240
15,600
15,600 $523,000

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $441M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.